Abiopharma

Rosen Law Firm Urges Concorde International Group Ltd. (NASDAQ: CIGL) Stockholders to Contact the Firm for Information About Their Rights

Faraday Future Confirms Receipt of Minimum Bid Deficiency Notice and 180-Day Extension from Nasdaq to Meet The $1 Per Share Minimum Bid Price Requirement

Securities Fraud Investigation Into Alibaba Group Holding Ltd. (BABA) Continues – Investors Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, A Leading Securities Fraud Law Firm

Pentair Announces Retirement of Chairman of the Board David A. Jones and Appointment of T. Michael Glenn

Bristol Myers Squibb - Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals forOpdivo® (nivolumab)

Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)

Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)

Bristol Myers Squibb Transforms the Classical Hodgkin Lymphoma Treatment Paradigm with Expanded U.S. and EMA Approvals for Opdivo® (nivolumab)

UTHR: Notification

e.l.f. Beauty Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of e.l.f. Beauty, Inc. - ELF